Form 4: Equifax CEO Mark Begor Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Equifax CEO Mark Begor exercised stock options and sold shares of common stock on February 13, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 13, 2025, Equifax CEO Mark W Begor exercised stock options to acquire 22,161 shares of Equifax common stock at a price of $175.48 per share.
- Simultaneously, Begor sold a total of 22,161 shares of Equifax common stock in a series of transactions at prices ranging from $250.7382 to $256.3083 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 14, 2024.
- Following these transactions, Begor directly owns 142,243 shares of Equifax common stock and indirectly owns 124,090 shares through various grantor retained annuity trusts (GRATs).
- The exercised stock option was granted with an exercise price of $175.48 and became exercisable in three equal annual increments beginning February 21, 2021, expiring on February 21, 2026.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a standard disclosure of insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative performance for the company.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to utilize 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The exercise of options and subsequent sale is a typical wealth management strategy.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across publicly traded companies.
- Comparing Begor's compensation and trading activity to CEOs of similar companies in the financial services or data analytics sectors (e.g., TransUnion, Experian) would provide a benchmark for assessing the magnitude and frequency of these transactions.
- The use of GRATs for estate planning is also a common practice among high-net-worth individuals, including corporate executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the pre-planned nature of the sales.
- Employees may view the CEO's stock sales with interest, but the existence of a 10b5-1 plan should reassure them that the sales are not based on any non-public information.
Key Dates
| Date | Description |
|---|---|
| 02/21/2021 | Stock option vesting began in three equal annual increments. |
| 11/14/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 02/13/2025 | Date of stock option exercise and share sales. |
| 02/18/2025 | Date of Form 4 filing. |
| 02/21/2026 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.